Haemonetics ROE 2010-2025 | HAE
Current and historical return on equity (ROE) values for Haemonetics (HAE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Haemonetics ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $0.16B | $0.88B | 18.69% |
| 2025-03-31 | $0.17B | $0.82B | 19.02% |
| 2024-12-31 | $0.13B | $0.91B | 14.13% |
| 2024-09-30 | $0.12B | $0.88B | 13.34% |
| 2024-06-30 | $0.11B | $0.91B | 12.32% |
| 2024-03-31 | $0.12B | $0.96B | 12.78% |
| 2023-12-31 | $0.13B | $0.94B | 14.32% |
| 2023-09-30 | $0.13B | $0.89B | 15.27% |
| 2023-06-30 | $0.14B | $0.87B | 17.06% |
| 2023-03-31 | $0.12B | $0.82B | 14.87% |
| 2022-12-31 | $0.10B | $0.78B | 12.70% |
| 2022-09-30 | $0.09B | $0.73B | 11.55% |
| 2022-06-30 | $0.07B | $0.77B | 9.22% |
| 2022-03-31 | $0.04B | $0.75B | 6.16% |
| 2021-12-31 | $0.02B | $0.73B | 3.24% |
| 2021-09-30 | $0.03B | $0.70B | 4.53% |
| 2021-06-30 | $0.07B | $0.68B | 9.30% |
| 2021-03-31 | $0.08B | $0.73B | 11.73% |
| 2020-12-31 | $0.11B | $0.72B | 16.88% |
| 2020-09-30 | $0.11B | $0.67B | 17.55% |
| 2020-06-30 | $0.10B | $0.61B | 16.31% |
| 2020-03-31 | $0.08B | $0.59B | 13.18% |
| 2019-12-31 | $0.08B | $0.58B | 13.23% |
| 2019-09-30 | $0.07B | $0.58B | 10.94% |
| 2019-06-30 | $0.05B | $0.59B | 7.68% |
| 2019-03-31 | $0.06B | $0.67B | 8.19% |
| 2018-12-31 | $0.05B | $0.64B | 6.64% |
| 2018-09-30 | $0.02B | $0.70B | 2.85% |
| 2018-06-30 | $0.02B | $0.67B | 2.89% |
| 2018-03-31 | $0.05B | $0.75B | 5.72% |
| 2017-12-31 | $-0.02B | $0.82B | -2.30% |
| 2017-09-30 | $0.00B | $0.80B | 0.52% |
| 2017-06-30 | $0.00B | $0.77B | 0.53% |
| 2017-03-31 | $-0.03B | $0.74B | -3.49% |
| 2016-12-31 | $0.02B | $0.77B | 2.16% |
| 2016-09-30 | $-0.06B | $0.75B | -7.98% |
| 2016-06-30 | $-0.07B | $0.72B | -8.86% |
| 2016-03-31 | $-0.06B | $0.72B | -7.31% |
| 2015-12-31 | $-0.05B | $0.72B | -6.29% |
| 2015-09-30 | $0.03B | $0.78B | 3.22% |
| 2015-06-30 | $0.02B | $0.79B | 2.44% |
| 2015-03-31 | $0.02B | $0.83B | 1.94% |
| 2014-12-31 | $0.03B | $0.83B | 3.51% |
| 2014-09-30 | $0.03B | $0.82B | 3.52% |
| 2014-06-30 | $0.04B | $0.82B | 4.76% |
| 2014-03-31 | $0.04B | $0.84B | 4.33% |
| 2013-12-31 | $0.04B | $0.83B | 4.80% |
| 2013-09-30 | $0.03B | $0.80B | 4.11% |
| 2013-06-30 | $0.02B | $0.77B | 2.84% |
| 2013-03-31 | $0.04B | $0.77B | 5.20% |
| 2012-12-31 | $0.05B | $0.78B | 5.92% |
| 2012-09-30 | $0.05B | $0.77B | 7.15% |
| 2012-06-30 | $0.06B | $0.76B | 8.35% |
| 2012-03-31 | $0.07B | $0.73B | 9.48% |
| 2011-12-31 | $0.07B | $0.71B | 10.07% |
| 2011-09-30 | $0.07B | $0.68B | 10.57% |
| 2011-06-30 | $0.08B | $0.71B | 11.97% |
| 2011-03-31 | $0.08B | $0.69B | 12.83% |
| 2010-12-31 | $0.06B | $0.65B | 10.50% |
| 2010-09-30 | $0.06B | $0.59B | 10.49% |
| 2010-06-30 | $0.06B | $0.57B | 10.04% |
| 2010-03-31 | $0.06B | $0.59B | 10.05% |
| 2009-12-31 | $0.07B | $0.57B | 12.06% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.628B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.889B | 27.07 |
| Boston Scientific (BSX) | United States | $156.325B | 37.28 |
| Stryker (SYK) | United States | $149.639B | 30.46 |
| EssilorLuxottica (ESLOY) | France | $141.259B | 0.00 |
| Medtronic (MDT) | Ireland | $119.046B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.750B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.950B | 25.13 |
| ResMed (RMD) | United States | $40.192B | 28.74 |
| Agilent Technologies (A) | United States | $35.696B | 23.06 |
| GE HealthCare Technologies (GEHC) | United States | $33.662B | 15.82 |
| Terumo (TRUMY) | Japan | $26.606B | 31.53 |
| Koninklijke Philips (PHG) | Netherlands | $26.557B | 17.57 |
| Insulet (PODD) | United States | $23.925B | 80.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.018B | 13.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.402B | 0.00 |
| Baxter (BAX) | United States | $12.681B | 9.80 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.061B | 29.61 |
| Lantheus Holdings (LNTH) | United States | $3.733B | 10.09 |
| Envista Holdings (NVST) | United States | $3.520B | 24.63 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.349B | 14.86 |
| Perrigo (PRGO) | Ireland | $3.266B | 8.16 |
| ICU Medical (ICUI) | United States | $3.151B | 21.46 |
| Acuren (TIC) | United States | $2.261B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.213B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.159B | 46.29 |
| QuidelOrtho (QDEL) | United States | $1.948B | 12.26 |
| Green Thumb Industries (GTBIF) | United States | $1.840B | 79.00 |
| AtriCure (ATRC) | United States | $1.838B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.519B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.503B | 17.74 |
| AdaptHealth (AHCO) | United States | $1.284B | 18.25 |
| Neogen (NEOG) | United States | $1.249B | 19.83 |
| BioLife Solutions (BLFS) | United States | $1.200B | 2505.00 |
| InMode (INMD) | Israel | $0.944B | 8.74 |
| Kestra Medical Technologies (KMTS) | United States | $0.829B | 0.00 |
| Valneva SE (VALN) | France | $0.753B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.740B | 0.00 |
| SNDL (SNDL) | Canada | $0.704B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.52 |
| Evolus (EOLS) | United States | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.479B | 16.50 |
| CeriBell (CBLL) | United States | $0.434B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.379B | 3.36 |
| Sanuwave Health (SNWV) | United States | $0.357B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.306B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Brainsway (BWAY) | Israel | $0.294B | 59.85 |
| High Tide (HITI) | Canada | $0.292B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.286B | 21.68 |
| Omeros (OMER) | United States | $0.283B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.242B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.199B | 16.63 |
| FitLife Brands (FTLF) | United States | $0.175B | 21.53 |
| Biote (BTMD) | United States | $0.170B | 5.64 |
| Jushi Holdings (JUSHF) | United States | $0.149B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.78 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 33.68 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 31.08 |
| United-Guardian (UG) | United States | $0.039B | 15.02 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Sharps Technology (STSS) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |